Clinical Trials Browser

Advanced Solid Tumor (Phase 1) × Injections × 90 days × Clear all

NCT07434609 2026-02-25

Evaluation of T320, an Anti-Tissue Factor Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors

Phase 1 Not yet recruiting

Other solid neoplasm

Advanced Solid Tumor (Phase 1)